ACE2 News and Research

RSS

What is the link between influenza vaccination and the severity of COVID-19 infection?

Researchers performed a systematic review and meta-analysis to investigate whether influenza vaccinations could reduce COVID-19 severity outcomes.

25 Aug 2022

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Researchers investigated the potential anti-COVID-19 activity of traditional Chinese medicine.

25 Aug 2022

Vertical transfer of humoral immune protection after maternal SARS-CoV-2 vaccination

In a new study, researchers assessed the presence, durability, and neutralization potency of immunoglobulin G and IgA antibodies against SARS-CoV-2 in breastfeeding infant stools, maternal plasma, and breast milk following maternal COVID-19 vaccination.

24 Aug 2022

What is the impact of a syntenin inhibitor in COVID-19 treatment?

In a new study, researchers assessed the impact of a syntenin inhibitor on SARS-CoV-2 entry.

24 Aug 2022

Transposable element expression changes in response to SARS-CoV-2 infection

Researchers observed that transposable element activation is impaired during infection with SARS-CoV-2.

24 Aug 2022

Investigating the missing link between COVID-19 and anosmia

A new study evaluated how SARS-CoV-2 infection leads to anosmia via chromatin structure disruption and OR dysregulation. For this purpose, publicly available Hi-C data of OSNs of SARS-CoV-2-infected and control human subjects were used.

23 Aug 2022

Epistasis leads to the reduction in genetic barrier to COVID-19 neutralizing antibody escape

A new study addresses the important question of how the SARS-CoV-2 virus would evolve in the future to be able to escape diverse and broadly neutralizing antibodies.

23 Aug 2022

SARS-CoV-2 breakthrough infection induces virus-specific nasal T-cells

A new study reports that hybrid immunity induced by vaccination and previous infection induces SARS-CoV-2-specific tissue-resident T-cells in the nasal cavity.

22 Aug 2022

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Researchers explored how effectively nanotechnology-based novel and potential vaccines, drugs, and monoclonal antibodies could combat the current and yet to emerge SARS-CoV-2 variants.

22 Aug 2022

Research reveals cetylpyridinium chloride in mouthwash shows anti-SARS-CoV-2 effects

A recent study has demonstrated the antiviral effectiveness of cetylpyridinium chloride against SARS-CoV-2 infection.

22 Aug 2022

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Researchers explored how the natural alterations inside the SARS-CoV-2 glycan barrier affect the spike protein dynamics.

22 Aug 2022

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

A recent study examines the potential effects of tobacco use on COVID-19.

21 Aug 2022

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Researchers assessed the SARS-CoV-2 variants of concern (VOCs) transmission dynamics and neutralization by vaccine-induced antibodies and monoclonal antibodies (mAbs).

19 Aug 2022

Host anti-viral factors and pathways regulating SARS-CoV-2 infection

In a new study, researchers identified host anti-viral factors and pathways regulating SARS-CoV-2 infection.

18 Aug 2022

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

Researchers investigated the role of the CD98 glycoprotein in inducing an inflammatory response to SARS-CoV-2 in patients of progressive fibrosis interstitial lung diseases, including the archetypal PFILD, idiopathic pulmonary fibrosis.

18 Aug 2022

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

Researchers demonstrated the relevance of the P681H spike mutation in the SARS-CoV-2 Alpha variant.

17 Aug 2022

Computational pipeline for the early identification of emerging SARS-CoV-2 variants

Researchers developed a computational pipeline for the early identification of emerging SARS-CoV-2 variants of interest by analyzing SARS-CoV-2 genome data and allocating risk scores on the basis of functional and epidemiological parameters.

16 Aug 2022

Rapid and efficient strategy for the development and design of SARS-CoV-2 neutralizing humanized nanobody constructs

Researchers developed humanized nanobodies that neutralize SARS-CoV-2.

16 Aug 2022

Scientists explore nanomolar inhibition of SARS-CoV-2 infection via unmodified peptide targeting spike protein pre-hairpin intermediate

In a new study, scientists identified an unmodified peptide addressing pre-hairpin spike (S) protein intermediate inhibiting SARS-CoV-2 infection.

15 Aug 2022

Mechanistic insights into engineered ACE2 receptor traps

Researchers determined the cryo-electron microscopic (cryo-EM) structures of engineered angiotensin-converting enzyme 2 (ACE2) receptor traps.

12 Aug 2022

ACE2 News and Research

What is the link between influenza vaccination and the severity of COVID-19 infection?

Researchers report large molecular compounds and nanoscale nanozyme of two traditional Chinese medicines may inhibit COVID-19 signaling

Vertical transfer of humoral immune protection after maternal SARS-CoV-2 vaccination

What is the impact of a syntenin inhibitor in COVID-19 treatment?

Transposable element expression changes in response to SARS-CoV-2 infection

Investigating the missing link between COVID-19 and anosmia

Epistasis leads to the reduction in genetic barrier to COVID-19 neutralizing antibody escape

SARS-CoV-2 breakthrough infection induces virus-specific nasal T-cells

How effective are nanotechnology-based vaccines, drugs, and antibodies to combat variants of SARS-CoV-2?

Research reveals cetylpyridinium chloride in mouthwash shows anti-SARS-CoV-2 effects

How natural alterations inside the SARS-CoV-2 glycan barrier affect spike protein dynamics

Smoking and the risk of contracting SARS-CoV-2 and COVID-19

SARS-CoV-2 variant neutralization and novel mAbs reveal protection against Omicron in new research

Host anti-viral factors and pathways regulating SARS-CoV-2 infection

CD98 identified as a key mediator of pro-fibrotic and acute inflammatory responses in the lung

The impact of the P681H spike mutation in the SARS-CoV-2 Alpha variant

Computational pipeline for the early identification of emerging SARS-CoV-2 variants

Rapid and efficient strategy for the development and design of SARS-CoV-2 neutralizing humanized nanobody constructs

Scientists explore nanomolar inhibition of SARS-CoV-2 infection via unmodified peptide targeting spike protein pre-hairpin intermediate

Mechanistic insights into engineered ACE2 receptor traps

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News